IPP Bureau

Thyrocare secures NABL accreditation for its Labs
Thyrocare secures NABL accreditation for its Labs

By IPP Bureau - December 27, 2024

Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation

Sumitomo Pharma America receives USFDA approval of vibegron for benign prostatic hyperplasia
Sumitomo Pharma America receives USFDA approval of vibegron for benign prostatic hyperplasia

By IPP Bureau - December 27, 2024

GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH

Yatharth Hospital becomes Uttar Pradesh's first JCI-accredited hospital
Yatharth Hospital becomes Uttar Pradesh's first JCI-accredited hospital

By IPP Bureau - December 26, 2024

JCI accreditation is recognized globally

Akums signs Rs. 1,760 crore CDMO agreement with a leading global pharma company
Akums signs Rs. 1,760 crore CDMO agreement with a leading global pharma company

By IPP Bureau - December 26, 2024

The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities

Kwality Pharmaceuticals receives approval for Tamoxifen 20mg Tablet in South Africa
Kwality Pharmaceuticals receives approval for Tamoxifen 20mg Tablet in South Africa

By IPP Bureau - December 26, 2024

This approval is a significant achievement in expanding the availability of this critical therapeutic,

Aarti Drugs receives EIR from USFDA for Tarapur API facility
Aarti Drugs receives EIR from USFDA for Tarapur API facility

By IPP Bureau - December 26, 2024

This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP

SVU to organise International Conference on Clinical Translation of Biomaterial-based Therapeutics and Devices on 6-7 Feb, 2025
SVU to organise International Conference on Clinical Translation of Biomaterial-based Therapeutics and Devices on 6-7 Feb, 2025

By IPP Bureau - December 26, 2024

The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”

Antara partners with Dr. Lal PathLabs to strengthen its geriatric care services
Antara partners with Dr. Lal PathLabs to strengthen its geriatric care services

By IPP Bureau - December 24, 2024

This curated geriatric care package - Varishtha Aarogya Vardaan -- includes a comprehensive range of essential blood tests specifically curated for seniors.

Tejnaksh Healthcare’s MD granted Indian patent for Pflow
Tejnaksh Healthcare’s MD granted Indian patent for Pflow

By IPP Bureau - December 24, 2024

Pflow is a revolutionary, disposable, and portable home based urine flow measurement test

Ikena Oncology and Inmagene Biopharmaceuticals announce agreement for merger
Ikena Oncology and Inmagene Biopharmaceuticals announce agreement for merger

By IPP Bureau - December 24, 2024

The transaction is expected to result in approximately $175 million to support further development of IMG-007

BASF sells food and health performance ingredients business to Louis Dreyfus Company
BASF sells food and health performance ingredients business to Louis Dreyfus Company

By IPP Bureau - December 24, 2024

Divestment is part of BASF’s strategic portfolio optimization

Syensqo and Emulseo collaborate to advance microfluidic technology in healthcare sector
Syensqo and Emulseo collaborate to advance microfluidic technology in healthcare sector

By IPP Bureau - December 24, 2024

Exploring new opportunities within the fast-growing market of microfluidics

KRAIBURG TPE's solutions upraises healthcare products for higher functionality
KRAIBURG TPE's solutions upraises healthcare products for higher functionality

By IPP Bureau - December 22, 2024

The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,

MSD enters into license agreement with Hansoh Pharma for investigational Oral GLP-1 receptor agonist
MSD enters into license agreement with Hansoh Pharma for investigational Oral GLP-1 receptor agonist

By IPP Bureau - December 22, 2024

Alembic Pharmaceuticals receives USFDA final approval for Divalproex Sodium Delayed-Release Capsules
Alembic Pharmaceuticals receives USFDA final approval for Divalproex Sodium Delayed-Release Capsules

By IPP Bureau - December 22, 2024

Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA

Latest Stories

Interviews

Packaging